Should long-acting injectable antipsychotics be used earlier and more frequent in bipolar disorder, type I?

Publikation: Bidrag til tidsskrift › Leder › Forskning › fagfællebedømt

Standard

Should long-acting injectable antipsychotics be used earlier and more frequent in bipolar disorder, type I? / Kessing, Lars Vedel.

I: Nordic Journal of Psychiatry, Bind 76, Nr. 7, 2022, s. 487-488.

Publikation: Bidrag til tidsskrift › Leder › Forskning › fagfællebedømt

Harvard

Kessing, LV 2022, 'Should long-acting injectable antipsychotics be used earlier and more frequent in bipolar disorder, type I?', Nordic Journal of Psychiatry, bind 76, nr. 7, s. 487-488. https://doi.org/10.1080/08039488.2021.2008000

APA

Kessing, L. V. (2022). Should long-acting injectable antipsychotics be used earlier and more frequent in bipolar disorder, type I? Nordic Journal of Psychiatry, 76(7), 487-488. https://doi.org/10.1080/08039488.2021.2008000

Vancouver

Kessing LV. Should long-acting injectable antipsychotics be used earlier and more frequent in bipolar disorder, type I? Nordic Journal of Psychiatry. 2022;76(7):487-488. https://doi.org/10.1080/08039488.2021.2008000

Author

Kessing, Lars Vedel. / Should long-acting injectable antipsychotics be used earlier and more frequent in bipolar disorder, type I?. I: Nordic Journal of Psychiatry. 2022 ; Bind 76, Nr. 7. s. 487-488.

Bibtex

@article{a1f084972961442c815863259931c599,

title = "Should long-acting injectable antipsychotics be used earlier and more frequent in bipolar disorder, type I?",

author = "Kessing, {Lars Vedel}",

year = "2022",

doi = "10.1080/08039488.2021.2008000",

language = "English",

volume = "76",

pages = "487--488",

journal = "Nordisk Psykiatrisk Tidsskrift",

issn = "0803-9496",

publisher = "Taylor & Francis",

number = "7",